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INTRODUCTION
In their paper evaluating a primary care-based multidisci-
plinary readmission prevention program, Cavanaugh and
colleagues describe the quality improvement processes they
underwent to develop, iteratively refine, implement and
then evaluate a program designed to improve post-discharge
planning and care transitions, thereby reducing
readmissions.1 Using a retrospective cohort study design,
they then describe the results of their program evaluation
comparing patients who have been discharged from their
hospital and exposed to a local innovation—a hospitaliza-
tion follow-up clinic—to a local comparison group matched
on readmission risk and admission timing. In unadjusted
analyses, program participants had significantly fewer
readmissions at 30 and 90 days, with non-significant trends
for lower emergency department visits, shorter median time
to first post-discharge follow-up visit, and higher achieve-
ment of hospital follow-up within 30 days.1 When they
adjusted for baseline differences between their intervention
and comparison groups, only the hazard of a 90-day
readmission was significantly lower in the intervention
group.
This paper provides an excellent example of the potential
for and challenges of identifying an appropriate and
comparable comparison group in non-experimental study
designs, as well as the value of what Jubelt and colleagues
described as “thick descriptions” of program content and
processes of implementation, in context such that actions
and behaviors become clear to outsiders.2 In this commen-
tary, I lay out the implications of both comparability and
context for evaluating quality improvement (QI) programs,
with an eye to their contribution to implementation and
spread of local innovations.
Comparability of Comparisons: Enhancing
Internal Validity
While even randomization does not always confer compa-
rability, the utility and internal validity of non-experimental
evaluation designs often rise or fall on the basis of the
comparability of the comparison group(s) used.3 The
purpose of a comparison group is to offer evidence of what
would have happened in the absence of the intervention to
the extent possible, enabling estimation of an incremental
advantage attributable to program implementation.4 There-
fore, the type and manner in which selection criteria are
applied, the availability of data and measures, and the
covariate adjustments that evaluators deploy to increase the
comparability of intervention vs. comparison groups be-
come essential design elements.5 Otherwise, potential
threats to internal validity begin to mount, undermining
confidence in the study’s findings.6
Cavanaugh and colleagues1 compared two groups of
patients that had been discharged from their hospital: (1) the
intervention group, members of whom had been exposed to
a hospitalization follow-up clinic; and (2) a comparison
group, derived using the same inclusion/exclusion criteria,
matched on a general readmission risk stratification score,
and whose index discharge was within a month of the
intervention patient to whom they were matched. To their
credit, Cavanaugh et al.'s approach reduced many common
validity threats by applying comparable criteria and similar
time trajectories (e.g., within a month of index discharges)
for both groups over the same 5-month time period and in
the same facility.
At the same time, each of these strengths may be
moderated by one or more challenges (Table 1). For
example, use of the same facility means that patients in
both intervention and comparison groups shared the same
area and organizational environments, which reduces the
need to adjust for contextual factors. However,
implementing a program in the same site simultaneously
increases the potential for contamination, as patients,
providers and staff with experience in the interventionPublished online March 14, 2014
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may co-mingle or otherwise influence referrals, partici-
pation or behavior. Single-site studies also limit external
validity, but all studies have to start somewhere, and a
rush to multi-site research without solid pilot evidence
would be unwarranted, not to mention prohibitively
expensive. The authors also applied the same inclusion/
exclusion criteria, increasing the comparability of inter-
vention and comparison patients. Yet only patients with
established primary care providers were eligible, among
other exclusions, limiting knowledge about how the
program might be deployed or tailored for other types
of patients. And while comparison group patients were
randomly sampled from the pool of eligible patients, the
factors driving program referral (let alone attendance/
participation) produce inherent selection effects.7
Matching comparison group patients to individual
intervention patients based on the risk of readmission
using a locally standardized risk classification scheme
also represented a methodological strength. The evalua-
tors’ approach to risk stratification and matching yielded
intervention and comparison group members of low,
moderate and high risk in equal proportions, seeking
comparability in a fundamental and inherent driver of
readmissions. At the same time, despite best efforts, the
intervention group ultimately included significantly more
patients with chronic obstructive pulmonary disease
(COPD) or asthma (46 % vs. 24 %) and fewer with
cirrhosis (4 % vs. 22 %) or depression (22 % vs.
44 %).1 As is commonly done, the authors adjusted for
these and other baseline differences in their final
analyses, as they focused on better understanding the
program’s independent effects.7 The extent to which the
baseline differences continued to be associated with
program participation after statistical adjustment is not
reported; understanding whether these differences had
meaningful implications for their findings may have
been a useful adjunct, especially for patients with
mental health conditions.
That said, the reality is that for every strength, any
number of challenges is always present. Criteria that seek to
homogenize patients into comparable, highly-controlled
groups to improve internal validity often limit our ability
to translate research and QI evidence into routine clinical
practice.8,9 Therefore, achieving comparability of interven-
tion and comparison groups in program evaluation requires
constant balancing of the demands of both internal and
external validity.
Implications of Context for Considering
External Validity, Implementation and Spread
A central tenet of external validity is the ability to
generalize beyond the circumstances of a particular study
to other patients, providers and practices.10 However, local
innovations, like the case presented here, are just
that—local—and reflect the environment within which
providers practice and patients experience care, and within
which quality improvement and evidence-based programs
may or may not take hold and work.11 As a result, area and
organizational contexts have substantial influences on
quality of care, the design and deployment of QI interven-
tions, and, ultimately, the implementation of evidence-based
practice and policy.12
Cavanaugh and colleagues1 again provide a strong
example for describing the local context within which they
developed, tested and evaluated their follow-up program for
individuals at risk for hospital readmission. They describe
their organizational context as a large, academic internal
medicine practice based at the University of North Carolina
(UNC) at Chapel Hill. The practice is further distinguished
by a 15-year history of QI activities, reflected by apparent
in-house QI capabilities (e.g., use of root cause analysis,
process mapping, small tests of change, run charts) and
their referenced peer-reviewed publications, as well as
NCQA recognition as a Level 3 PCMH. This latter
recognition reflects the highest level a practice can achieve
on standards of access/continuity, population management,
planning and care management, self-management support/
community resources, tracking/coordinating care, and per-
formance measurement/improvement.13 Not surprising for a
Table 1. Strengths and Challenges Associated with Comparison
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Level 3 PCMH practice, they also enjoy the benefits of an
electronic health record (EHR), which clearly enabled
access to data for both comparison and intervention
patients. They also provide caseload and workload param-
eters: they serve approximately 14,000 patients, about 270
of whom are admitted to UNC Hospitals on a monthly basis
and about 20 % (54) of whom, in turn, are readmitted
within 30 days on average.
This description provides an extremely useful backdrop
for understanding context and its implications for external
validity, which in turn informs how readily other practices
might be able to adopt (or need to adapt) the hospitalization
follow-up clinic as a model. First, to what other types of
practices might the evaluation results generalize? A major
advantage is its reliance on practice-based research. As
Lawrence Green notes, “If we want more evidence-based
practice, we need more practice-based evidence.”14 While
this study was not part of a practice-based research network
(PBRN), the practice under study appears to have operated
under similar precepts: use of the practice as a “laboratory”
for testing healthcare innovations with engagement of
frontline providers and staff in the framing and design of
potential solutions to problems with which they have
experience, benefiting from elements of QI and participa-
tory action research.15,16 As an academic practice, however,
it may be difficult to generalize to non-academic settings,
where the majority of Americans obtain their health care.
The multi-level partnerships between the UNC practice and
UNC Hospitals may also not be easily reproducible
elsewhere, yet are essential to implementation and spread
of evidence-based practice.17,18 EHR implementation is also
very uneven in the U.S., with significant organizational
determinants of variation in use and quality of decision
support and data mining.
Adoption decisions by other organizations may be
predicated on the extent to which being an enriched,
academic practice actually served as a core attribute of the
intervention and its implementation. While not defined as
such in the paper, in “realistic evaluations,” interventions
are conceptualized and evaluated as being inextricably
linked to their contexts, such that “mechanisms [of change]
may be more or less effective in producing their intended
outcomes, depending on their interaction with various
contextual factors.”19,20 For this innovation to have impacts
beyond its relatively narrow context, readers may therefore
need to consider how they might have to adapt their practice
and/or the innovation to fit their own organizational
milieu.21,22
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